Qi Zhang Xiaojian Zhu Bo Liu Yicheng Zhang Yi Xiao
10.3389/fimmu.2023.1127868
Front Immunol
2023 Mar 17;14:1127868.
asct burkitt’s lymphoma car-t tp53 mutations relapsed/refractory
CC BY
https://pubmed.ncbi.nlm.nih.gov/37006273/
Burkitt Lymphoma / genetics Burkitt Lymphoma / therapy Receptors, Chimeric Antigen / genetics
Burkitt Lymphoma / genetics Burkitt Lymphoma / therapy Receptors, Chimeric Antigen / genetics Case Reports Research Support, Non-U.S. Gov't Cell- and Tissue-Based Therapy Humans Mutation Neoplasm Recurrence, Local Tumor Suppressor Protein p53 / genetics Receptors, Chimeric Antigen TP53 protein, human Tumor Suppressor Protein p53
PMC10063779
37006273
Case report: Sandwich therapy of CAR-T combined with ASCT: Sequential CAR-T cell therapy with ASCT after remission with CAR-T therapy caused long-term survival in a patient with relapsed/refractory Burkitt's lymphoma with TP53 mutations
2023